Earlier diagnosis of acute kidney injury awaits effective therapy

Kidney International

Volumn 79, Issue 11, 2011, Pages 1159-1161

  Westenfelder, Christof ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CLUSTERIN; CREATININE; ERYTHROPOIETIN; FATTY ACID BINDING PROTEIN; GENTAMICIN; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE ALPHA; GLUTATHIONE TRANSFERASE MU; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; LIVER TYPE FATTY ACID BINDING PROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OSTEOPONTIN; RENAL PAPILLARY ANTIGEN 1; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL (TOPIC); CREATININE BLOOD LEVEL; EARLY DIAGNOSIS; HISTOPATHOLOGY; HUMAN; KIDNEY FUNCTION TEST; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RELIABILITY; RENAL PROTECTION; REVIEW; SENSITIVITY AND SPECIFICITY; URINALYSIS;

EID: 79956013684     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.19     Document Type: Note

References (13)

1. Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol 2008; 48: 463-493. (Pubitemid 351738161)
2. Cruz DN, Ricci Z, Ronco C. Clinical review: RIFLE and AKIN-time for reappraisal. Crit Care 2009; 13: 211; doi:10.1186/cc7759.
3. Waikar SS, Sabbisetti VS, Bonventre JV. Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney Int 2010; 78: 486-494.
4. Mori K, Lee HT, Rapoport D et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005; 115: 610-621. (Pubitemid 40322235)
5. Ichimura T, Asseldonk EJ, Humphreys BD et al. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest 2008; 118: 1657-1668. (Pubitemid 351632370)
6. Rouse RL, Zhang J, Stewart SR et al. Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in rats. Kidney Int 2011; 79: 1186-1197.
7. Togel F, Isaac J, Hu Z et al. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 2005; 67: 1772-1784. (Pubitemid 40577712)
8. Hsu CY, Ordonez JD, Chertow GM et al. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int 2008; 74: 101-107. (Pubitemid 351841887)
9. Allgren RL, Marbury TC, Rahman SN et al. Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 1997; 336: 828-834. (Pubitemid 27132980)
10. Hirschberg R, Kopple J, Lipsett P et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 1999; 55: 2423-2432. (Pubitemid 29256497)
11. Endre ZH, Walker RJ, Pickering JW et al. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int 2010; 77: 1020-1030.
12. Togel FE, Westenfelder C. Mesenchymal stem cells: a new therapeutic tool for AKI. Nat Rev Nephrol 2010; 6: 179-183.
13. Westenfelder C. Unexpected renal actions of erythropoietin. Exp Nephrol 2002; 10: 294-298. (Pubitemid 36151243)